WeVote
Log In

Bill

CA

Bill

S 664

Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.

2024-2025 Regular Session Introduced by Carmen Amato and 12 co-sponsors

Bill redirects New Jersey tobacco tax revenue to guarantee $10 million annually for cancer research through a protected, non-lapsing fund.

Referred to Senate Budget and Appropriations Committee
#alcotaxes #commissions #disease
0
WeVote Research Nonpartisan
Bill Summary · S 664

Legislative bill overview

S 664 redirects tobacco tax revenues to increase annual funding for the New Jersey Commission on Cancer Research from an unspecified current amount to $10 million and establishes a dedicated, non-lapsing fund to protect this revenue stream from being redirected or eliminated in future budget cycles.

Why is this important

Cancer research funding directly impacts the state's ability to develop treatments, conduct clinical trials, and support scientists working on cancer prevention and care. Creating a non-lapsing fund ensures consistent, predictable revenue rather than subject-to-annual-budget negotiations, potentially accelerating research initiatives.

Potential points of contention

  • Tobacco tax allocation debate: Tobacco taxes are traditionally used for healthcare, cessation programs, and general revenue; dedicating $10 million specifically to research may reduce funding available for smoking prevention or treatment programs that could prevent cancer cases initially
  • Non-lapsing fund concerns: Permanent fund dedications reduce legislative flexibility during budget crises and limit lawmakers' ability to redirect resources to competing urgent priorities
  • Revenue sustainability questions: Tobacco tax revenues decline as smoking rates decrease; the bill doesn't address whether $10 million remains feasible as the tax base shrinks, potentially creating future funding gaps

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.